Go to deals
Private Equity | Consumer & Retail

FlyCap and the founder have sold Bio2You to INVL Baltic Sea Growth Fund

Latvia-based growth capital fund FlyCap has sold its 39% stake in Bio2You to INVL Baltic Sea Growth Fund. The remaining 61% of the shares was sold by the founder and CEO of the company. As a result of this transaction, INVL Baltic Sea Growth Fund now controls 100% of Bio2You.

Bio2You is a cosmetics manufacturer based in Latvia. The company offers private label and contract manufacturing services, as well as selling products under their own brand. It produces skin, body, hair and oral care products, and other bath and shower items (bath salts and bath bombs), as well as their own soap base. The brand has a particular focus on anti-aging products.

INVL Baltic Sea Growth Fund is a closed-end investment fund intended for professional investors and is one of the largest private equity investment funds in the Baltic region. It is focused on growth capital, buy-out, and buy-and-build investments.

Oaklins’ team in Latvia advised the sellers through all stages of this transaction.

Service
M&A sell-side
Parties

Talk to the deal team

 Valērija  Lieģe

Valērija Lieģe

Partner
Riga, Latvia
Oaklins Baltics
 Reinholds R. Razums

Reinholds R. Razums

Senior Associate
Riga, Latvia
Oaklins Baltics
 Monta  Jaunarāja

Monta Jaunarāja

Associate
Riga, Latvia
Oaklins Baltics

Related deals

Confirma Software has acquired Quick Systems
Private Equity | TMT

Confirma Software has acquired Quick Systems

Quick Systems AS has become part of Confirma Software, backed by Abry Partners.

Learn more
Dan Deal has been acquired by Shufersal
Consumer & Retail

Dan Deal has been acquired by Shufersal

The owners of Dan Deal have sold the company to Shufersal.

Learn more
Agar Scientific has been acquired by Calibre Scientific
Private Equity | Healthcare

Agar Scientific has been acquired by Calibre Scientific

Agar Scientific Ltd. (Agar) has been sold to Molecular Dimensions Limited, a subsidiary of Calibre Scientific, Inc., a US-based life sciences company, owned by international private investment firm StoneCalibre.

Learn more